Dark Forest Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Dark Forest Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,397	Closed	-$547K	–	803
2025 Q4	$547K	Sell	25,397 -21,505	-46%	-$418K	0.03%	801
2025 Q3	$716K	Sell	46,902 -248,234	-84%	-$3.23M	0.03%	833
2025 Q2	$2.61M	Buy	295,136 +115,699	+64%	+$1.02M	0.1%	332
2025 Q1	$1.4M	Buy	+179,437	New	+$1.5M	0.06%	518

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Dark Forest Capital Management's AVDL Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 25,397 shares — an estimated $547K sold.

Dark Forest Capital Management first reported a position in AVDL in Q1 2025 and held it in 4 quarters. The position peaked at $2.61M in Q2 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Dark Forest Capital Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Dark Forest Capital Management sold 25,397 Avadel Pharmaceuticals shares in Q1 2026, an estimated $547K.
Dark Forest Capital Management first reported a position in Avadel Pharmaceuticals in Q1 2025 and held it in 4 quarters.
Dark Forest Capital Management's Avadel Pharmaceuticals position peaked at $2.61M in Q2 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.